<VariationArchive RecordType="classified" VariationID="1784222" VariationName="NM_000251.3(MSH2):c.-15_211+105del" VariationType="Deletion" Accession="VCV001784222" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2022-11-29" MostRecentSubmission="2023-09-03">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1849781" VariationID="1784222">
      <GeneList>
        <Gene Symbol="MSH2" FullName="mutS homolog 2" GeneID="4436" HGNC_ID="HGNC:7325" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2p21-16.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="47403067" stop="47709830" display_start="47403067" display_stop="47709830" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="47630205" stop="47710366" display_start="47630205" display_stop="47710366" Strand="+" />
          </Location>
          <OMIM>609309</OMIM>
          <Haploinsufficiency last_evaluated="2021-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MSH2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MSH2">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000251.3(MSH2):c.-15_211+105del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2p21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="47403172" stop="47403502" display_start="47403172" display_stop="47403502" variantLength="331" positionVCF="47403171" referenceAlleleVCF="AGGAGGTGAGGAGGTTTCGACATGGCGGTGCAGCCGAAGGAGACGCTGCAGTTGGAGAGCGCGGCCGAGGTCGGCTTCGTGCGCTTCTTTCAGGGCATGCCGGAGAAGCCGACCACCACAGTGCGCCTTTTCGACCGGGGCGACTTCTATACGGCGCACGGCGAGGACGCGCTGCTGGCCGCCCGGGAGGTGTTCAAGACCCAGGGGGTGATCAAGTACATGGGGCCGGCAGGTGAGGGCCGGGACGGCGCGTGCTGGGGAGGGACCCGGGGCCTTGTGGCGCGGCTCCTTTCCCGCCTCAGAGAGTGGGCGGTGAGCAGCCTCTCCAGTGC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="47630311" stop="47630641" display_start="47630311" display_stop="47630641" variantLength="331" positionVCF="47630310" referenceAlleleVCF="AGGAGGTGAGGAGGTTTCGACATGGCGGTGCAGCCGAAGGAGACGCTGCAGTTGGAGAGCGCGGCCGAGGTCGGCTTCGTGCGCTTCTTTCAGGGCATGCCGGAGAAGCCGACCACCACAGTGCGCCTTTTCGACCGGGGCGACTTCTATACGGCGCACGGCGAGGACGCGCTGCTGGCCGCCCGGGAGGTGTTCAAGACCCAGGGGGTGATCAAGTACATGGGGCCGGCAGGTGAGGGCCGGGACGGCGCGTGCTGGGGAGGGACCCGGGGCCTTGTGGCGCGGCTCCTTTCCCGCCTCAGAGAGTGGGCGGTGAGCAGCCTCTCCAGTGC" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.47630316_47630646del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.47630316_47630646del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.47403177_47403507del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.47403177_47403507del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007110.2" sequenceAccession="NG_007110" sequenceVersion="2" change="g.5054_5384del">
            <Expression>NG_007110.2:g.5054_5384del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_095167.1" sequenceAccession="NG_095167" sequenceVersion="1" change="g.381_711del">
            <Expression>NG_095167.1:g.381_711del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001258281.1" sequenceAccession="NM_001258281" sequenceVersion="1" change="c.-31+2_13+105del">
            <Expression>NM_001258281.1:c.-31+2_13+105del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001582" Type="initiator_codon_variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000251.3" sequenceAccession="NM_000251" sequenceVersion="3" change="c.-15_211+105del" MANESelect="true">
            <Expression>NM_000251.3:c.-15_211+105del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001582" Type="initiator_codon_variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_218" sequenceAccession="LRG_218">
            <Expression>LRG_218:g.5054_5384del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000251.3(MSH2):c.-15_211+105del AND Hereditary cancer-predisposing syndrome" Accession="RCV002417159" Version="1">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-04-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-04-02" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-11-29" MostRecentSubmission="2023-09-03">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15713769</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15942939</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15943554</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16142001</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16826164</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17453009</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19930554</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30521064</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5208333" SubmissionDate="2022-11-11" DateLastUpdated="2023-09-03" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a190230" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002721560" DateUpdated="2023-09-03" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-04-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15713769</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15942939</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15943554</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16142001</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16826164</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17453009</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19930554</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30521064</ID>
          </Citation>
          <Comment>The c.-20_211+100DEL331 pathogenic gross deletion spans the 5' untranslated region through coding exon 1 in the MSH2 gene. Gross deletions of the 5'UTR region through coding exon 1 of MSH2 have been reported in multiple unrelated families meeting Amsterdam criteria for HPPCC/Lynch syndrome (B&amp;eacute;couarn Y et al. Gastroenterol. Clin. Biol. 2005 Jun-Jul;29(6-7):667-75; Zavodna K et al. BMC Cancer. 2009 Nov 20;9:405; Ambry internal data). Gross deletions of exon 1 have also been reported in multiple HNPCC/Lynch families (van der Klift H et al. Genes Chromosomes Cancer. 2005;44(2):123-38; Casey G et al. JAMA. 2005 Feb 16;293(7):799-809; Grabowski M et al. Genet. Test. 2005 Summer;9(2):138-46). Furthermore, loss of MSH2/MSH6 protein expression on immunohistochemistry (IHC) and/or high microsatellite instability (MSI-H) has been identified in Lynch syndrome associated tumors from individuals with gross deletions of the 5'UTR region through coding exon 1 and gross deletions of exon 1 (B&amp;eacute;couarn Y et al. Gastroenterol. Clin. Biol. 2005;29:667-75; Ponti G et al. J. Invest. Dermatol., 2006 Oct;126:2302-7; Overbeek LI et al. Br. J. Cancer, 2007 May;96:1605-12; Jiang W et al. Int. J. Cancer, 2019 05;144:2161-2168; Ambry internal data). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function due to an abnormal transcript or truncated protein. As such, this alteration is interpreted as a disease causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry General Variant Classification Scheme_2022</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/5hsvndk6/ambry_general_variant_classification_scheme_2022.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MSH2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000251.1:c.-20_211+100del331</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5208333" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

